Form 4: Oramed CSO Donates 86,166 Shares

Miriam Kidron, Chief Scientific Officer and Director of Oramed Pharmaceuticals Inc., reported a charitable donation of 86,166 shares of common stock.

Summary

• Miriam Kidron, Chief Scientific Officer and Director of Oramed Pharmaceuticals Inc., reported a transaction involving the company's common stock.
• On January 14, 2026, Kidron disposed of 86,166 shares of common stock through a charitable donation.
• No monetary value was received for the donated shares, as it was not a market transaction.
• Following this transaction, Kidron beneficially owns 1,343,498 shares of Oramed Pharmaceuticals Inc. common stock directly.
• The reporting person is not affiliated with, and has no control over, the donee.

Sentiment

Score: 5

Explanation: A charitable donation by an insider is generally neutral for the company's operational performance, though it slightly reduces the insider's direct stake. It reflects personal philanthropy rather than a market-driven decision.

Positives

• The transaction represents a charitable donation by a key executive, indicating philanthropic activity.

Negatives

• The Chief Scientific Officer's direct beneficial ownership of common stock decreased by 86,166 shares.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

• "This transaction represents a charitable donation and is not a market transaction, thus no price has been reported."
• "No value was received for the donated shares."
• "The Reporting Person is not affiliated with, and has no control over, the donee."

Industry Context

This filing reports an individual insider transaction, which is a personal financial decision by an executive and does not directly reflect broader industry trends or competitive dynamics within the pharmaceutical sector.

Stakeholder Impact

• Shareholders: The transaction represents a slight reduction in insider ownership, but is unlikely to have a significant impact on the company's share price or overall market perception, as it was a non-market charitable donation.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

This Form 4 reports a charitable donation by a key executive, which is a personal financial decision and not indicative of the company's operational performance or future prospects. It does not provide sufficient information to alter an investment thesis, thus a 'hold' recommendation is maintained based solely on this filing.

Keywords

Oramed Pharmaceuticals, ORMP, Miriam Kidron, Form 4, Insider Transaction, Charitable Donation, Common Stock, Officer, Director, Share Ownership